Novel 99mTc radiolabeled folate complexes with PEG linkers for FR-positive tumor imaging: synthesis and biological evaluation

Improved PET Imaging of Tumors in Mice Using a Novel 18 F-Folate Conjugate with an Albumin-Binding Entity

(2013) Cindy R. Fischer et al.   MOLECULAR IMAGING AND BIOLOGY

In Vitro and in Vivo Evaluation of an Innocuous Drug Cocktail To Improve the Quality of Folic Acid Targeted Nuclear Imaging in Preclinical Research

(2013) Cristina Müller et al.   MOLECULAR PHARMACEUTICS

Reduction of renal uptake of 111In-DOTA-labeled and A700-labeled RAFT-RGD during integrin αvβ3 targeting using single photon emission computed tomography and optical imaging

(2012) Arnaud Briat et al.   CANCER SCIENCE

DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid-Targeted 177Lu-Radionuclide Tumor Therapy in Mice

(2012) C. Muller et al.   JOURNAL OF NUCLEAR MEDICINE

The synthesis of pteroyl-lys conjugates and its application as Technetium-99m labeled radiotracer for folate receptor-positive tumor targeting

(2011) Hongjuan Guo et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Synthesis and biological evaluation of receptor-based tumor imaging agent: 99mTc-folate-glucaric acid

(2011) Mehmet Onursal et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Effects of the Amino Acid Linkers on the Melanoma-Targeting and Pharmacokinetic Properties of 111In-Labeled Lactam Bridge-Cyclized  -MSH Peptides

(2011) H. Guo et al.   JOURNAL OF NUCLEAR MEDICINE

Synthesis and in vitro/in vivo evaluation of 99mTc-labeled folate conjugates for folate receptor imaging

(2011) Jie Lu et al.   NUCLEAR MEDICINE AND BIOLOGY

The role of pemetrexed as maintenance treatment in advanced NSCLC: a Phase III randomized trial

(2010) Cesare Gridelli et al.   EXPERT OPINION ON PHARMACOTHERAPY

Design and synthesis of 99mTc-citro-folate for use as a tumor-targeted radiopharmaceutical

(2010) Burcu Altiparmak et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Folic Acid Conjugates for Nuclear Imaging of Folate Receptor-Positive Cancer

(2010) C. Muller et al.   JOURNAL OF NUCLEAR MEDICINE

Effects of the Antifolates Pemetrexed and CB3717 on the Tissue Distribution of99mTc-EC20 in Xenografted and Syngeneic Tumor-Bearing Mice†

(2010) Cristina Müller et al.   MOLECULAR PHARMACEUTICS

Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues

(2009) Edgar J. Rolleman et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy

(2009) Cristina Müller et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

111In-Labeled Lactam Bridge-Cyclized α-Melanocyte Stimulating Hormone Peptide Analogues for Melanoma Imaging

(2008) Yubin Miao et al.   BIOCONJUGATE CHEMISTRY

Evaluation of the Pharmacokinetic Effects of Various Linking Group Using the111In-DOTA-X-BBN(7−14)NH2Structural Paradigm in a Prostate Cancer Model

(2008) Jered C. Garrison et al.   BIOCONJUGATE CHEMISTRY

Tumor detection using folate receptor-targeted imaging agents

(2008) Emanuela I. Sega et al.   CANCER AND METASTASIS REVIEWS

Improving Tumor Uptake and Excretion Kinetics of99mTc-Labeled Cyclic Arginine-Glycine-Aspartic (RGD) Dimers with Triglycine Linkers

(2008) Jiyun Shi et al.   JOURNAL OF MEDICINAL CHEMISTRY

Pemetrexed Improves Tumor Selectivity of 111In-DTPA-Folate in Mice with Folate Receptor-Positive Ovarian Cancer

(2008) C. Muller et al.   JOURNAL OF NUCLEAR MEDICINE

Exploratory Study of 99mTc-EC20 Imaging for Identifying Patients with Folate Receptor-Positive Solid Tumors

(2008) R. E. Fisher et al.   JOURNAL OF NUCLEAR MEDICINE

Improving Tumor-Targeting Capability and Pharmacokinetics of99mTc-Labeled Cyclic RGD Dimers with PEG4Linkers

(2008) Lijun Wang et al.   MOLECULAR PHARMACEUTICS

Coligand effects on the solution stability, biodistribution and metabolism of the 99mTc-labeled cyclic RGDfK tetramer

(2007) Shuang Liu et al.   NUCLEAR MEDICINE AND BIOLOGY